MA35534B1 - Compound for the treatment and prophylaxis of respiratory syncytial virus disease - Google Patents

Compound for the treatment and prophylaxis of respiratory syncytial virus disease

Info

Publication number
MA35534B1
MA35534B1 MA36918A MA36918A MA35534B1 MA 35534 B1 MA35534 B1 MA 35534B1 MA 36918 A MA36918 A MA 36918A MA 36918 A MA36918 A MA 36918A MA 35534 B1 MA35534 B1 MA 35534B1
Authority
MA
Morocco
Prior art keywords
compound
treatment
respiratory syncytial
syncytial virus
prophylaxis
Prior art date
Application number
MA36918A
Other languages
French (fr)
Inventor
Li Chen
Yongfu Liu
Lichun Feng
Song Feng
Lu Gao
Tao Guo
Mengwei Huang
Chungen Liang
Lisha Wang
Jason Christopher Wong
Xihan Wu
Hongying Yun
Xiufang Zheng
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/065499 external-priority patent/WO2013020993A1/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA35534B1 publication Critical patent/MA35534B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un composé de formule (i), ainsi qu'un sel pharmaceutiquement acceptable de celui-ci, où r1 à r10, a, q, x et y sont tels que définis dans la description et dans les revendications, pouvant être utilisé comme médicament pour le traitement du virus respiratoire syncytial.The invention relates to a compound of formula (i), and a pharmaceutically acceptable salt thereof, wherein r1 to r10, a, q, x and y are as defined in the description and in the claims, which may be used as a medicine for the treatment of respiratory syncytial virus.

MA36918A 2011-08-11 2014-04-15 Compound for the treatment and prophylaxis of respiratory syncytial virus disease MA35534B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2011078258 2011-08-11
PCT/EP2012/065499 WO2013020993A1 (en) 2011-08-11 2012-08-08 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease

Publications (1)

Publication Number Publication Date
MA35534B1 true MA35534B1 (en) 2014-10-02

Family

ID=53139243

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36918A MA35534B1 (en) 2011-08-11 2014-04-15 Compound for the treatment and prophylaxis of respiratory syncytial virus disease

Country Status (3)

Country Link
MA (1) MA35534B1 (en)
UA (1) UA110849C2 (en)
ZA (1) ZA201400442B (en)

Also Published As

Publication number Publication date
UA110849C2 (en) 2016-02-25
ZA201400442B (en) 2015-09-30

Similar Documents

Publication Publication Date Title
MA35432B1 (en) Compound for the treatment and prophylaxis of respiratory syncytial virus disease
MX2021007432A (en) Compounds and compositions for inhibiting the activity of shp2.
MA35285B1 (en) indazoles
NZ721534A (en) Process for the preparation of n-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine
MA38323B1 (en) Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
MA37866B1 (en) Aza-indazole or diaza-indazole derivatives for the treatment of pain
MA40225A (en) SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS
MA38239A1 (en) New pyridine derivatives
MA35342B1 (en) Piperidinyl compounds useful as inhibitors of tankyrase
MA37888A1 (en) Coated pharmaceutical composition containing regorafenib
MA40308A1 (en) Pyridine-2-amides useful as cb2 agonists
EA201491606A1 (en) KINURENIN-3-MONOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR USE
MA38403A1 (en) New pyrazole derivatives modulators specific for cb2
EA201391486A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE
GEP20186880B (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
MX2013008056A (en) 1,4-oxazepines as bace1 and/or bace2 inhibitors.
MA38315B1 (en) Heterocycle-substituted tetracyclic compounds and methods for their use in the treatment of viral diseases
UA113750C2 (en) COMPOSITION (+) - 2- $ 1- (3-ethoxy-4-methoxyphenyl) -2-methanesulfonylethyl] -4-ACETYLAMINOISOINDOLINE-1,3-DIONE
MA35347B1 (en) Therapeutic methods
MA38679A1 (en) Cxcr7 receiver modulators
MX2014003701A (en) Compounds for the treatment and prophylaxis of respiratory syncytial virus disease.
MA38307A1 (en) 4-hydroxy-2-methyl-5- (propan-2-ylidene) cyclohex-3-enecarbaldehyde for the prevention and treatment of cognitive, neurodegenerative or neuronal disease
EA201270653A1 (en) ANTAGONIST DPI ITS APPLICATION
FR2961695B1 (en) USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SKIN DISORDERS
MA41975B1 (en) Fusible aminohydrothiazine derivatives containing tetrahydrofuran useful in the treatment of alzheimer's disease